Carbenicillin indanyl sodium oral therapy of urinary tract infections

1973 ◽  
Vol 131 (5) ◽  
pp. 679-681
Author(s):  
G. R. Hodges
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Oral Therapy ◽  
Tract Infections

Oral therapy for urinary tract infections in infants aged 3 to 12 months

2008 ◽  
Vol 27 (9) ◽  
pp. 887-889
Author(s):  
G. Claret Teruel ◽  
J. J. García García ◽  
M. Fernández de Sevilla Estrach ◽  
E. Corrales Magin ◽  
V. Trenchs Sáinz de la Maza ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Oral Therapy ◽  
Tract Infections

scholarly journals Ertapenem versus Ceftriaxone Followed by Appropriate Oral Therapy for Treatment of Complicated Urinary Tract Infections in Adults: Results of a Prospective, Randomized, Double-Blind Multicenter Study

2002 ◽  
Vol 46 (9) ◽  
pp. 2895-2900 ◽  
Author(s):  
Kevin M. Tomera ◽  
Emmanuel A. Burdmann ◽  
Oscar G. Pamo Reyna ◽  
Qi Jiang ◽  
Wendy M. Wimmer ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Acute Pyelonephritis ◽  
Oral Therapy ◽  
Randomized Study ◽  
Success Rates ◽  
Double Blind ◽  
Treatment Groups ◽  
The Difference ◽  
Tract Infections

ABSTRACT The efficacy and safety of intravenous (i.v.) ertapenem (1 g once a day) with the option to switch to an oral agent for treatment of adults with complicated urinary tract infections (UTIs) were compared with that of i.v. ceftriaxone (1 g daily) with the same oral switch option in a multicenter, double-blind, prospective, randomized study. At entry, 592 patients were assigned to one of two strata: acute pyelonephritis or other complicated UTI without acute pyelonephritis. After a minimum of 3 days, patients could be switched to an oral antimicrobial agent. A total of 159 patients in the ertapenem group and 171 patients in the ceftriaxone group were microbiologically evaluable. Approximately 95% of patients in each treatment group were switched to oral therapy. The most common pathogens were Escherichia coli and Klebsiella pneumoniae. At the primary efficacy endpoint 5 to 9 days after treatment, 91.8% of patients who received ertapenem and 93.0% of those who received ceftriaxone had a favorable microbiological response (95% confidence interval for the difference, adjusting for strata, −7.6 to 5.1%), indicating that outcomes in the two treatment groups were equivalent. Microbiological success rates for the two treatment groups were similar when compared by stratum and also by severity of infection. The frequency and severity of drug-related adverse events were generally similar in both treatment groups. In this study, ertapenem was as effective as ceftriaxone for the initial treatment of complicated UTIs in adults, was generally well tolerated, and had a similar overall safety profile.

90: A Systematic Review of Urinary Tract Infections Following Transposition of Bowel Segments into Urinary Tract

2004 ◽  
Vol 171 (4S) ◽  
pp. 24-24 ◽  
Author(s):  
Nabi Ghulam ◽  
Sze M. Yong ◽  
Eng Ong ◽  
Adrian Grant ◽  
Gladys C. McPherson ◽  
...  
Keyword(s):  
Systematic Review ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Tract Infections ◽  
Bowel Segments

89: How Should we Investigate Community Treated Men with Urinary Tract Infections?

2004 ◽  
Vol 171 (4S) ◽  
pp. 23-24
Author(s):  
Jay Khastgir ◽  
Mark Mantle ◽  
Andrew Dickinson
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Tract Infections
Sign in / Sign up

Export Citation Format

Share Document